MHRA and NICE Offer Streamlined Approvals Pathway for Pharmaceutical Companies Friday 10 October, 2025 – Pharmaceutical companies producing qualifying medicines can now take advantage of a streamlined approvals pathway, thanks to the collaborative efforts of the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE).
No responses yet